Swedish biopharmaceutical company Sobi made annual losses in some years before 2015. However, the company made profits which increased significantly since then, with a peak in 2019 of around 3.3 billion Swedish kronor. In 2023, profits amounted to some 2.4 billion kroner. The company's full name is Swedish Orphan Biovitrum AB. Sobi is specialized on the treatment of rare diseases. This statistic illustrates the annual profit/loss of Sobi from 2009 to 2023.
Annual profit/loss of Sobi from 2009 to 2023
(in million SEK)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Sobi. (April 2, 2024). Annual profit/loss of Sobi from 2009 to 2023 (in million SEK) [Graph]. In Statista. Retrieved December 30, 2024, from https://www.statista.com/statistics/946974/annual-profit-loss-of-sobi/
Sobi. "Annual profit/loss of Sobi from 2009 to 2023 (in million SEK)." Chart. April 2, 2024. Statista. Accessed December 30, 2024. https://www.statista.com/statistics/946974/annual-profit-loss-of-sobi/
Sobi. (2024). Annual profit/loss of Sobi from 2009 to 2023 (in million SEK). Statista. Statista Inc.. Accessed: December 30, 2024. https://www.statista.com/statistics/946974/annual-profit-loss-of-sobi/
Sobi. "Annual Profit/Loss of Sobi from 2009 to 2023 (in Million Sek)." Statista, Statista Inc., 2 Apr 2024, https://www.statista.com/statistics/946974/annual-profit-loss-of-sobi/
Sobi, Annual profit/loss of Sobi from 2009 to 2023 (in million SEK) Statista, https://www.statista.com/statistics/946974/annual-profit-loss-of-sobi/ (last visited December 30, 2024)
Annual profit/loss of Sobi from 2009 to 2023 (in million SEK) [Graph], Sobi, April 2, 2024. [Online]. Available: https://www.statista.com/statistics/946974/annual-profit-loss-of-sobi/
